Literature DB >> 28387462

Identification and electrophysiological characterization of early left atrial structural remodeling as a predictor for atrial fibrillation recurrence after pulmonary vein isolation.

Atsuhiko Yagishita1, Dina Sparano1, Ivan Cakulev1, J Rod Gimbel1, Timothy Phelan1, Hossam Mustafa1, Samer De Oliveira1, Judith Mackall1, Mauricio Arruda1.   

Abstract

BACKGROUND: Voltage-guided substrate ablation following pulmonary vein isolation (PVI) improves atrial fibrillation (AF) ablation outcomes. However, by setting an upper voltage cutoff of 0.5 mV during sinus rhythm (SR) to guided substrate ablation using electroanatomic voltage mapping (EAVM), mildly affected low-voltage area (maLVA) may be undetected. We sought to determine the optimal bipolar voltage cutoff to identify maLVA, its electrogram complexity, and the implication on ablation outcome. METHODS AND
RESULTS: Left atrial (LA) EAVMs were obtained in patients without AF and structural heart disease (control) to devise a voltage cutoff to identify maLVA. Subsequently, we investigated 100 patients without low-voltage area (LVA) of < 0.5 mV who underwent PVI alone. In our 6 control cohorts, 95% of LA regional bipolar voltage was > 1.17 mV. maLVA, defined as <1.1 mV, was present in 43% of AF patients, associated with higher prevalence of abnormal electrograms (44.1% vs. 4.4%, P < 0.001). During a median of 2.4 years, patients with maLVA had higher recurrence rate (Log-rank P < 0.001), and maLVA was an independent predictor for recurrence in a multivariate analysis (hazard ratio [HR] 3.944; 95% confidence interval [CI] 1.292-12.042; P = 0.016).
CONCLUSIONS: A control-derived LA voltage cutoff of <1.1 mV for EAVM in SR reveals maLVA, harboring abnormal electrograms, as an independent predictor for recurrences after PVI alone in patients without LVA (< 0.5 mV). Adjunctive maLVA-guided substrate ablation targeting mildly remodeled and potentially arrhythmogenic LA substrate may further improve the long-term outcome of AF ablation.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; pulmonary vein; remodeling

Mesh:

Year:  2017        PMID: 28387462     DOI: 10.1111/jce.13211

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  9 in total

Review 1.  Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation.

Authors:  Falco Kosich; Katja Schumacher; Tatjana Potpara; Gregory Y Lip; Gerhard Hindricks; Jelena Kornej
Journal:  Clin Cardiol       Date:  2019-01-14       Impact factor: 2.882

2.  Rabbit model to simulate the residual conduction gaps after radiofrequency ablation on the anterior wall of left atrial appendage.

Authors:  Huaner Ni; Ying Zhuge; Lin Li; Weifeng Li; Congcong Zhao; Yujie Wang; Fang Wang
Journal:  J Interv Card Electrophysiol       Date:  2018-04-10       Impact factor: 1.900

3.  Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation.

Authors:  Katja Schumacher; Petra Büttner; Nikolaos Dagres; Philipp Sommer; Borislav Dinov; Gerhard Hindricks; Andreas Bollmann; Jelena Kornej
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

4.  Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation.

Authors:  Jelena Kornej; Katja Schumacher; Borislav Dinov; Falco Kosich; Philipp Sommer; Arash Arya; Daniela Husser; Andreas Bollmann; Gregory Y H Lip; Gerhard Hindricks
Journal:  Sci Rep       Date:  2018-08-23       Impact factor: 4.379

5.  Combination of doxorubicin liposomes with left atrial appendage radiofrequency catheter ablation to reduce post-ablation recovery of electrical conduction.

Authors:  Ying Zhuge; Huan-Er Ni; Yu-Jie Wang; Mu-Ye He; Jun-Shan Wang; Feng Gao; Fang Wang
Journal:  Int J Nanomedicine       Date:  2018-12-27

Review 6.  Left atrial voltage mapping: defining and targeting the atrial fibrillation substrate.

Authors:  Iain Sim; Martin Bishop; Mark O'Neill; Steven E Williams
Journal:  J Interv Card Electrophysiol       Date:  2019-05-10       Impact factor: 1.900

7.  Echocardiographic and Electrocardiographic Determinants of Atrial Cardiomyopathy Identify Patients with Atrial Fibrillation at Risk for Left Atrial Thrombogenesis.

Authors:  Taiyuan Huang; Schurr Patrick; Louisa Katharina Mayer; Björn Müller-Edenborn; Martin Eichenlaub; Martin Allgeier; Jürgen Allgeier; Heiko Lehrmann; Christoph Ahlgrim; Marius Bohnen; Simon Schoechlin; Dietmar Trenk; Nikolaus Jander; Franz Josef Neumann; Thomas Arentz; Amir Jadidi
Journal:  J Clin Med       Date:  2022-02-28       Impact factor: 4.241

8.  Atrial low voltage areas: A comparison between atrial fibrillation and sinus rhythm.

Authors:  Ana Andrés Lahuerta; Carlos Roberto; Francisco Javier Saiz; Óscar Cano; Laura Martínez-Mateu; Pau Alonso; Assumpció Saurí; Aurelio Quesada; Joaquín Osca
Journal:  Cardiol J       Date:  2021-10-13       Impact factor: 2.737

9.  A systematic review and meta-analysis of the safety and efficacy of left atrial substrate modification in atrial fibrillation patients with low voltage areas.

Authors:  Shaobin Mao; Hongxuan Fan; Leigang Wang; Yongle Wang; Xun Wang; Jianqi Zhao; Bing Yu; Yao Zhang; Wenjing Zhang; Bin Liang
Journal:  Front Cardiovasc Med       Date:  2022-09-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.